News

Patients with less neuronal damage, determined by low spinal fluid pNFH, had a 48% reduction in the risk of death by adding IL-2 to riluzole.
MaaT033, an experimental oral therapy that uses bacteria to restore balance in the gut, may slow ALS progression, a study ...
Patients given Neuronata-R who progressed more slowly saw significant gains in CAFS, slower declines in ALSFRS-R scores, and ...
Massachusetts General Hospital's 2025 MGH ALS Young Investigator Awards went to three scholars doing ALS research.
ALS Awareness Month amplifies difficult emotions for columnist. It's one of the reasons why sharing is important.
The ALS therapy ATLX-1282 was developed with AIchemab's platform, which uses AI to identify therapeutic targets for difficult ...
Clene will soon meet with the Food and Drug Administration to discuss analyses that could support an application for ...
Columnist Dagmar Munn considers when she decided to share the news that she had ALS — and it wasn't when she felt "ready" to ...
Implanting a sensor in the brain helped detect intended speech and allowed control of a computer for a man with ALS in a ...
Neurosense Therapeutics said it's producing its ALS therapy PrimeC at a commercial scale as it prepares for potential ...
Columnist Kristin Neva, inspired by a Bon Iver song, investigates old journals as she thinks about the rhythm of her life.
The nationwide event will cost $20, with all funds benefiting Augie's Quest, which was founded to fund research and raise ALS ...